Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Mortality profiles among people living with HIV/AIDS: comparison between Rio de Janeiro and other federative units between 1999 and 2015.

Paula AA, Pires DF, Alves Filho P, Lemos KRV, Veloso VG, Grinsztejn B, Pacheco AG.

Rev Bras Epidemiol. 2020 Mar 20;23:e200017. doi: 10.1590/1980-549720200017. eCollection 2020. Portuguese, English.

2.

Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis.

Perazzo H, Castro R, Luz PM, Banholi M, Goldenzon RV, Cardoso SW, Grinsztejn B, Veloso VG.

Bull World Health Organ. 2020 Mar 1;98(3):188-197K. doi: 10.2471/BLT.19.231522. Epub 2019 Nov 8.

3.

Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis.

Castro R, Perazzo H, de Araujo LAMM, Gutierres IG, Grinsztejn B, Veloso VG.

PLoS One. 2020 Feb 21;15(2):e0229143. doi: 10.1371/journal.pone.0229143. eCollection 2020.

4.

Do men who have sex with men who report alcohol and illicit drug use before/during sex (chemsex) present moderate/high risk for substance use disorders?

Torres TS, Bastos LS, Kamel L, Bezerra DRB, Fernandes NM, Moreira RI, Garner A, Veloso VG, Grinsztejn B, De Boni RB.

Drug Alcohol Depend. 2020 Apr 1;209:107908. doi: 10.1016/j.drugalcdep.2020.107908. Epub 2020 Feb 11.

PMID:
32078972
5.

Prevalence of induced abortion and associated factors in a cohort of women living with HIV/AIDS, Rio de Janeiro, Brazil, 1996-2016.

Domingues RMSM, Silva CMFPD, Grinsztejn BGJ, Moreira RI, Derrico M, Andrade AC, Friedman RK, Luz PM, Coelho LE, Veloso VG.

Cad Saude Publica. 2020 Feb 10;36Suppl 1(Suppl 1):e00201318. doi: 10.1590/0102-311X00201318. eCollection 2020. Portuguese, English.

6.

HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells.

Caetano DG, de Paula HHS, Bello G, Hoagland B, Villela LM, Grinsztejn B, Veloso VG, Morgado MG, Guimarães ML, Côrtes FH.

PLoS One. 2020 Feb 5;15(2):e0228745. doi: 10.1371/journal.pone.0228745. eCollection 2020.

7.
8.

Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries.

Pettit AC, Jenkins CA, Blevins Peratikos M, Yotebieng M, Diero L, Do CD, Ross J, Veloso VG, Hawerlander D, Marcy O, Shepherd BE, Fenner L, Sterling TR; International Epidemiology Databases to Evaluate AIDS (IeDEA) Consortium.

J Int AIDS Soc. 2019 Dec;22(12):e25423. doi: 10.1002/jia2.25423.

9.

Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil.

Ferreira MF, Brito-Santos F, Trilles L, Almeida MA, Wanke B, Veloso VG, Nunes EP, Lazera MDS.

Mycoses. 2020 Feb;63(2):145-150. doi: 10.1111/myc.13032. Epub 2019 Nov 24.

PMID:
31715053
10.

Putting health equity at heart of universal coverage-the need for national programmes of action.

Friedman EA, Gostin LO, Kavanagh MM, Periago MR, Marmot M, Coates A, Binagwaho A, Mukherjee J, Chowdhury M, Robinson T, Veloso VG, Wang C, Were M.

BMJ. 2019 Oct 25;367:l5901. doi: 10.1136/bmj.l5901. No abstract available.

PMID:
31653611
11.

Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline.

Coelho LE, Torres TS, Veloso VG, Landovitz RJ, Grinsztejn B.

Lancet HIV. 2019 Nov;6(11):e788-e799. doi: 10.1016/S2352-3018(19)30238-3. Epub 2019 Sep 23. Review.

PMID:
31558423
12.

Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.

Marins LMS, Torres TS, Leite IDC, Moreira RI, Luz PM, Hoagland B, Kallas EG, Madruga JV, Liu AY, Anderson PL, Grinsztejn B, Veloso VG.

PLoS One. 2019 Aug 20;14(8):e0221281. doi: 10.1371/journal.pone.0221281. eCollection 2019.

13.

An Internet-Based HIV Self-Testing Program to Increase HIV Testing Uptake Among Men Who Have Sex With Men in Brazil: Descriptive Cross-Sectional Analysis.

De Boni RB, Veloso VG, Fernandes NM, Lessa F, Corrêa RG, Lima RS, Cruz M, Oliveira J, Nogueira SM, de Jesus B, Reis T, Lentini N, Miranda RL, Bingham T, Johnson CC, Barbosa Junior A, Grinsztejn B.

J Med Internet Res. 2019 Aug 1;21(8):e14145. doi: 10.2196/14145.

14.

Authorship Correction: Factors Associated With Willingness to Use Pre-Exposure Prophylaxis in Brazil, Mexico, and Peru: Web-Based Survey Among Men Who Have Sex With Men.

Torres TS, Konda KA, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, Hoagland B, Diaz S, Pimenta C, Benedetti M, Lopez-Gatell H, Robles-Garcia R, Grinsztejn B, Caceres C, Veloso VG; ImPrEP Study Group.

JMIR Public Health Surveill. 2019 Jul 18;5(3):e15504. doi: 10.2196/15504.

15.

A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up.

Caetano DG, Côrtes FH, Bello G, de Azevedo SSD, Hoagland B, Villela LM, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG.

BMC Infect Dis. 2019 Jul 5;19(1):588. doi: 10.1186/s12879-019-4229-3.

16.

The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention.

Luz PM, Veloso VG, Grinsztejn B.

Curr Opin HIV AIDS. 2019 Sep;14(5):366-373. doi: 10.1097/COH.0000000000000564.

17.

Factors Associated With Willingness to Use Pre-Exposure Prophylaxis in Brazil, Mexico, and Peru: Web-Based Survey Among Men Who Have Sex With Men.

Torres TS, Konda KA, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, Hoagland B, Diaz S, Pimenta C, Bennedeti M, Lopez-Gatell H, Robles-Garcia R, Grinsztejn B, Caceres C, Veloso VG; ImPrEP Study Group.

JMIR Public Health Surveill. 2019 Jun 17;5(2):e13771. doi: 10.2196/13771. Erratum in: JMIR Public Health Surveill. 2019 Jul 18;5(3):e15504.

18.

Factors associated with PrEP awareness according to age and willingness to use HIV prevention technologies: the 2017 online survey among MSM in Brazil.

Torres TS, Luz PM, De Boni RB, de Vasconcellos MTL, Hoagland B, Garner A, Moreira RI, Veloso VG, Grinsztejn B.

AIDS Care. 2019 Oct;31(10):1193-1202. doi: 10.1080/09540121.2019.1619665. Epub 2019 May 23.

PMID:
31122033
19.

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.

Spinelli MA, Glidden DV, Anderson PL, Gandhi M, McMahan VM, Defechereux P, Schechter M, Veloso VG, Chariyalertsak S, Guanira JV, Bekker LG, Buchbinder SP, Grant RM.

AIDS Res Hum Retroviruses. 2019 Sep;35(9):788-793. doi: 10.1089/AID.2018.0297. Epub 2019 Jun 19.

PMID:
31119944
20.

Effectiveness of direct-acting agents for hepatitis C and liver stiffness changing after sustained virological response.

Fernandes FF, Piedade J, Guimaraes L, Nunes EP, Chaves U, Goldenzon RV, Cardoso SW, Duarte J, Grinsztejn B, Veloso VG, Pereira G, Perazzo H.

J Gastroenterol Hepatol. 2019 Dec;34(12):2187-2195. doi: 10.1111/jgh.14707. Epub 2019 Jun 26.

PMID:
31062880
21.

Proviral Quasispecies Diversity Is Not Associated With Virologic Breakthrough or CD4+ T Cell Loss in HIV-1 Elite Controllers.

de Azevedo SSD, Côrtes FH, Delatorre E, Ribeiro-Alves M, Hoagland B, Grinsztejn B, Veloso VG, Morgado MG, Bello G.

Front Microbiol. 2019 Apr 2;10:673. doi: 10.3389/fmicb.2019.00673. eCollection 2019.

22.

Transcendendo: A Cohort Study of HIV-Infected and Uninfected Transgender Women in Rio de Janeiro, Brazil.

Ferreira ACG, Coelho LE, Jalil EM, Luz PM, Friedman RK, Guimarães MRC, Moreira RC, Eksterman LF, Cardoso SW, Castro CV, Derrico M, Moreira RI, Fernandes B, Monteiro L, Kamel L, Pacheco AG, Veloso VG, Grinsztejn B.

Transgend Health. 2019 Apr 5;4(1):107-117. doi: 10.1089/trgh.2018.0063. eCollection 2019.

23.

Reduction of HIV-1 Reservoir Size and Diversity After 1 Year of cART Among Brazilian Individuals Starting Treatment During Early Stages of Acute Infection.

Leite TF, Delatorre E, Côrtes FH, Ferreira ACG, Cardoso SW, Grinsztejn B, de Andrade MM, Veloso VG, Morgado MG, Guimarães ML.

Front Microbiol. 2019 Feb 11;10:145. doi: 10.3389/fmicb.2019.00145. eCollection 2019.

24.

The Intersection of HIV, Social Vulnerability, and Reproductive Health: Analysis of Women Living with HIV in Rio de Janeiro, Brazil from 1996 to 2016.

Zachek CM, Coelho LE, Domingues RMSM, Clark JL, De Boni RB, Luz PM, Friedman RK, de Andrade ÂCV, Veloso VG, Lake JE, Grinsztejn B.

AIDS Behav. 2019 Jun;23(6):1541-1551. doi: 10.1007/s10461-019-02395-x.

PMID:
30652206
25.

Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.

de Paula HHS, Ferreira ACG, Caetano DG, Delatorre E, Teixeira SLM, Coelho LE, João EG, de Andrade MM, Cardoso SW, Grinsztejn B, Veloso VG, Morgado MG, Guimarães ML, Côrtes FH.

Retrovirology. 2018 Dec 12;15(1):76. doi: 10.1186/s12977-018-0458-6.

26.

HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.

de Azevedo SSD, Delatorre E, Côrtes FH, Hoagland B, Grinsztejn B, Veloso VG, Souza TML, Morgado MG, Bello G.

AIDS. 2019 Mar 1;33(3):399-410. doi: 10.1097/QAD.0000000000002090.

PMID:
30531316
27.

Health-related quality of life assessment among people living with HIV in Rio de Janeiro, Brazil: a cross-sectional study.

Castro R, De Boni RB, Luz PM, Velasque L, Lopes LV, Medina-Lara A, Cardoso SW, De Oliveira MS, Friedman RK, Grinsztejn B, Veloso VG.

Qual Life Res. 2019 Apr;28(4):1035-1045. doi: 10.1007/s11136-018-2044-8. Epub 2018 Nov 10.

PMID:
30415417
28.

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.

Perazzo H, Cardoso SW, Yanavich C, Nunes EP, Morata M, Gorni N, da Silva PS, Cardoso C, Almeida C, Luz P, Veloso VG, Grinsztejn B.

J Int AIDS Soc. 2018 Nov;21(11):e25201. doi: 10.1002/jia2.25201.

29.

Congenital Cytomegalovirus and HIV Perinatal Transmission.

Adachi K, Xu J, Ank B, Watts DH, Camarca M, Mofenson LM, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Machado DM, Ceriotto M, Morgado MG, Bryson YJ, Veloso VG, Grinsztejn B, Mirochnick M, Moye J, Nielsen-Saines K; MPH for the NICHD HPTN 040 Study Team.

Pediatr Infect Dis J. 2018 Oct;37(10):1016-1021. doi: 10.1097/INF.0000000000001975.

30.

Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.

Caetano DG, Côrtes FH, Bello G, Teixeira SLM, Hoagland B, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG.

Retrovirology. 2018 Sep 10;15(1):62. doi: 10.1186/s12977-018-0444-z.

31.

Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil.

Jalil EM, Grinsztejn B, Velasque L, Ramos Makkeda A, Luz PM, Moreira RI, Kamel L, Fernandes NM, Ferreira ACG, Hoagland B, Wagner S, Liu A, McFarland W, Buchbinder S, Veloso VG, Wilson E; for Transcender Study Team.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):445-452. doi: 10.1097/QAI.0000000000001839.

32.

Accuracy of quick sequential organ failure assessment score to predict mortality in hospitalized patients with suspected infection in an HIV/AIDS reference centre in Rio de Janeiro, Brazil.

Moreira J, Paixão A, Oliveira J, Jaló W, Manuel O, Rodrigues R, Oliveira A, Tinoco L, Lima J, Grinsztejn B, Veloso VG, Japiassú AM, Lamas CC.

Clin Microbiol Infect. 2019 Jan;25(1):113.e1-113.e3. doi: 10.1016/j.cmi.2018.08.003. Epub 2018 Aug 15.

33.

Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas.

Coelho L, Rebeiro PF, Castilho JL, Caro-Vega Y, Mejia FA, Cesar C, Cortes CP, Padgett D, McGowan CC, Veloso VG, Sterling TR, Grinsztejn B, Shepherd BE, Luz PM.

AIDS Patient Care STDS. 2018 Aug;32(8):306-313. doi: 10.1089/apc.2018.0028. Erratum in: AIDS Patient Care STDS. 2018 Sep 1;32(9):379.

34.

Plasmatic Levels of IL-18, IP-10, and Activated CD8+ T Cells Are Potential Biomarkers to Identify HIV-1 Elite Controllers With a True Functional Cure Profile.

Côrtes FH, de Paula HHS, Bello G, Ribeiro-Alves M, de Azevedo SSD, Caetano DG, Teixeira SLM, Hoagland B, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG.

Front Immunol. 2018 Jul 11;9:1576. doi: 10.3389/fimmu.2018.01576. eCollection 2018.

35.

Self-testing, communication and information technology to promote HIV diagnosis among young gay and other men who have sex with men (MSM) in Brazil.

De Boni RB, Lentini N, Santelli AC, Barbosa A Jr, Cruz M, Bingham T, Cota V, Correa RG, Veloso VG, Grinsztejn B.

J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25116. doi: 10.1002/jia2.25116. No abstract available.

36.

Zika Virus Infection and Differential Diagnosis in a Cohort of HIV-Infected Patients.

Calvet GA, Brasil P, Siqueira AM, Zogbi HE, de Santis Gonçalves B, da Silva Santos A, Lupi O, Valls de Souza R, Damasceno Dos Santos Rodrigues C, da Silveira Bressan C, Wakimoto MD, Saraiva de Araújo E, Cardoso Dos Santos I, Georg I, Ribeiro Nogueira RM, Veloso VG, Bispo de Filippis AM.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):237-243. doi: 10.1097/QAI.0000000000001777.

PMID:
29912006
37.

Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses.

Castro R, Crathorne L, Perazzo H, Silva J, Cooper C, Varley-Campbell J, Marinho DS, Haasova M, Veloso VG, Anderson R, Hyde C.

BMC Med Res Methodol. 2018 Jun 13;18(1):53. doi: 10.1186/s12874-018-0515-9.

38.

PrEP adopted by the brazilian national health system: What is the size of the demand?

Luz PM, Benzaken A, Alencar TM, Pimenta C, Veloso VG, Grinsztejn B.

Medicine (Baltimore). 2018 May;97(1S Suppl 1):S75-S77. doi: 10.1097/MD.0000000000010602.

39.

Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.

Bakal DR, Coelho LE, Luz PM, Clark JL, De Boni RB, Cardoso SW, Veloso VG, Lake JE, Grinsztejn B.

J Antimicrob Chemother. 2018 Aug 1;73(8):2177-2185. doi: 10.1093/jac/dky145.

40.

The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.

Luz PM, Osher B, Grinsztejn B, Maclean RL, Losina E, Stern ME, Struchiner CJ, Parker RA, Freedberg KA, Mesquita F, Walensky RP, Veloso VG, Paltiel AD.

J Int AIDS Soc. 2018 Mar;21(3):e25096. doi: 10.1002/jia2.25096.

41.

Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG; PrEP Brasil Study Team.

Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.

PMID:
29467098
42.

Syndemics among individuals enrolled in the PrEP Brasil Study.

De Boni RB, Machado IK, De Vasconcellos MTL, Hoagland B, Kallas EG, Madruga JV, Fernandes NM, Cerqueira NB, Moreira RI, Goulart SP, Veloso VG, Grinsztejn B, Luz PM.

Drug Alcohol Depend. 2018 Apr 1;185:168-172. doi: 10.1016/j.drugalcdep.2017.12.016. Epub 2018 Feb 10.

PMID:
29454927
43.

Awareness of Prevention Strategies and Willingness to Use Preexposure Prophylaxis in Brazilian Men Who Have Sex With Men Using Apps for Sexual Encounters: Online Cross-Sectional Study.

Torres TS, De Boni RB, de Vasconcellos MT, Luz PM, Hoagland B, Moreira RI, Veloso VG, Grinsztejn B.

JMIR Public Health Surveill. 2018 Jan 22;4(1):e11. doi: 10.2196/publichealth.8997.

44.

Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission.

Adachi K, Xu J, Yeganeh N, Camarca M, Morgado MG, Watts DH, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado DM, Bryson YJ, Grinsztejn B, Moye J, Klausner JD, Bristow CC, Dickover R, Mirochnick M, Nielsen-Saines K; NICHD HPTN 040 Study Team.

PLoS One. 2018 Jan 5;13(1):e0189851. doi: 10.1371/journal.pone.0189851. eCollection 2018.

45.

Human Immunodeficiency Virus Antiretroviral Resistance and Transmission in Mother-Infant Pairs Enrolled in a Large Perinatal Study.

Yeganeh N, Kerin T, Ank B, Watts DH, Camarca M, Joao EC, Pilotto JH, Veloso VG, Bryson Y, Gray G, Theron G, Dickover R, Morgado MG, Santos B, Kreitchmann R, Mofenson L, Nielsen-Saines K.

Clin Infect Dis. 2018 May 17;66(11):1770-1777. doi: 10.1093/cid/cix1104.

46.

Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil.

Moreira J, Castro R, Lamas C, Ribeiro S, Grinsztejn B, Veloso VG.

Int J Infect Dis. 2018 Apr;69:11-19. doi: 10.1016/j.ijid.2017.12.014. Epub 2017 Dec 15.

47.

Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.

Jalil EM, Luz PM, Quintana M, Friedman RK, Madeira RMDS, Andrade AC, Chicarino J, Moreira RI, Derrico M, Levi JE, Russomano F, Veloso VG, Grinsztejn B.

Braz J Infect Dis. 2018 Jan - Feb;22(1):16-23. doi: 10.1016/j.bjid.2017.10.007. Epub 2017 Dec 6.

48.

Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.

Perazzo H, Jorge MJ, Silva JC, Avellar AM, Silva PS, Romero C, Veloso VG, Mujica-Mota R, Anderson R, Hyde C, Castro R.

BMC Gastroenterol. 2017 Nov 23;17(1):119. doi: 10.1186/s12876-017-0676-8. Review.

49.

Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.

Oliveira RVC, Shimakura SE, Campos DP, Hökerberg YHM, Victoriano FP, Ribeiro S, Veloso VG, Grinsztejn B, Carvalho MS.

AIDS Care. 2018 May;30(5):551-559. doi: 10.1080/09540121.2017.1391984. Epub 2017 Oct 23.

PMID:
29058481
50.

HIV testing and the care continuum among transgender women: population estimates from Rio de Janeiro, Brazil.

Jalil EM, Wilson EC, Luz PM, Velasque L, Moreira RI, Castro CV, Monteiro L, Garcia ACF, Cardoso SW, Coelho LE, McFarland W, Liu AY, Veloso VG, Buchbinder S, Grinsztejn B.

J Int AIDS Soc. 2017 Sep 19;20(1):21873. doi: 10.7448/IAS.20.1.21873. Erratum in: J Int AIDS Soc. 2018 Jan 22;21(1):e25047.

Supplemental Content

Loading ...
Support Center